Exagen shareholders back directors, auditor and pay
Exagen Inc. reported the results of its 2026 annual meeting of stockholders held on June 9, 2026.
Rhea-AI Filing Summary
Exagen Inc. reported the results of its 2026 annual meeting of stockholders held on June 9, 2026. Stockholders elected two Class I directors to three-year terms expiring at the 2029 annual meeting: Tina S. Nova, Ph.D., who received 8,094,349 votes for and 220,954 withheld, and Scott Kahn, Ph.D., who received 6,295,837 votes for and 2,019,466 withheld, with 8,663,346 broker non-votes for each.
Stockholders also ratified the appointment of BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 16,955,368 votes for, 4 against, and 23,277 abstentions. In an advisory vote, stockholders approved the compensation of the company’s named executive officers, with 8,271,156 votes for, 22,870 against, 21,277 abstentions, and 8,663,346 broker non-votes.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Tina S. Nova, Ph.D.: 8,094,349 votes
Votes for Scott Kahn, Ph.D.: 6,295,837 votes
Broker non-votes on director elections: 8,663,346 votes
+4 more
7 metrics
Votes for Tina S. Nova, Ph.D.
8,094,349 votes
Election as Class I director at 2026 annual meeting
Votes for Scott Kahn, Ph.D.
6,295,837 votes
Election as Class I director at 2026 annual meeting
Broker non-votes on director elections
8,663,346 votes
For each Class I director election
Auditor ratification votes for
16,955,368 votes
Ratification of BDO USA, P.C. for FY ending Dec. 31, 2026
Auditor ratification abstentions
23,277 votes
Ratification of BDO USA, P.C.
Say-on-pay votes for
8,271,156 votes
Advisory approval of named executive officer compensation
Say-on-pay broker non-votes
8,663,346 votes
Advisory vote on executive compensation
Key Terms
broker non-votes, independent registered public accounting firm, advisory vote, emerging growth company, +1 more
5 terms
broker non-votes financial
"Name | Votes For | Votes Withheld | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory vote financial
"approved, by an advisory vote, the compensation of the Company’s named executive officers"
An advisory vote is a shareholder poll that expresses investors’ approval or concern about a company’s policy, executive pay, board decisions or other governance matters but does not legally force the company to act. Think of it like a customer survey: it signals investor sentiment and can pressure management to change course, so investors watch the result as a guide to future governance, risk and potential shifts in strategy.
emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
named executive officers financial
"the compensation of the Company’s named executive officers as disclosed in the Proxy Statement"
Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Exagen Inc. (XGN) stockholders approve at the 2026 annual meeting?
Exagen stockholders elected two Class I directors, ratified BDO USA, P.C. as auditor for 2026, and approved, on an advisory basis, executive compensation as disclosed in the April 27, 2026 proxy statement.
Who was elected to Exagen Inc. (XGN) board at the 2026 annual meeting?
Stockholders elected Tina S. Nova, Ph.D. and Scott Kahn, Ph.D. as Class I directors for three-year terms expiring at the 2029 annual meeting, with each continuing until a successor is duly elected and qualified.
How did Exagen Inc. (XGN) stockholders vote on the 2026 auditor ratification?
Stockholders ratified BDO USA, P.C. as Exagen’s independent registered public accounting firm for the year ending December 31, 2026, with 16,955,368 votes for, 4 votes against, and 23,277 abstentions recorded.
Was Exagen Inc. (XGN) executive compensation approved in the 2026 say-on-pay vote?
Yes. In the advisory say-on-pay vote, 8,271,156 votes were cast for Exagen’s named executive officer compensation, 22,870 against, 21,277 abstained, and 8,663,346 were broker non-votes, resulting in approval.
When was Exagen Inc. (XGN) 2026 annual meeting of stockholders held?
Exagen held its 2026 annual meeting of stockholders on June 9, 2026. The meeting covered director elections, ratification of the independent auditor for 2026, and an advisory vote on executive compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
